Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taisuke Uehara

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Cancer Science|July 26, 2014
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer modelsYasuhiro Funahashi, Kiyoshi Okamoto, Yusuke Adachi, et al.
Cancer Cell|February 26, 2019
Targeting an RNA-Binding Protein Network in Acute Myeloid LeukemiaEric Wang, Sydney X Lu, Alessandro Pastore, et al.
Cancer Science|October 27, 2024
Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first-in-human phase I studyChigusa Morizane, Makoto Ueno, Tatsuya Ioka, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Cancer Science|July 26, 2014
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer modelsYasuhiro Funahashi, Kiyoshi Okamoto, Yusuke Adachi, et al.
Cancer Cell|February 26, 2019
Targeting an RNA-Binding Protein Network in Acute Myeloid LeukemiaEric Wang, Sydney X Lu, Alessandro Pastore, et al.
Cancer Science|October 27, 2024
Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first-in-human phase I studyChigusa Morizane, Makoto Ueno, Tatsuya Ioka, et al.
Pageof 2